Eyal S. Ron

Eyal S. Ron Email and Phone Number

Co-Founder and Partner @ SBH BioVenture
Boston, MA, US
Eyal S. Ron's Location
Greater Boston, United States
About Eyal S. Ron

Dr. Eyal S. Ron is a seasoned serial entrepreneur and strategic advisor with over 30 years of experience in drug development, medical devices, cosmeceuticals, and nutraceuticals. He excels in guiding start-ups from inception to exit, combining scientific expertise with business acumen. Renowned for being an exceptional out-of-the-box thinker and solution provider, Dr. Ron is adept at helping organizations redefine their agile strategies, transforming decision-making and empowering teams to deliver value early and effectively. Dr. Ron serves on multiple corporate boards, offering strategic guidance while mentoring emerging entrepreneurs. His expertise and mentorship make him a valuable asset to any organization in the life sciences and medical innovation sectors.

Eyal S. Ron's Current Company Details
SBH BioVenture

Sbh Bioventure

View
Co-Founder and Partner
Boston, MA, US
Eyal S. Ron Work Experience Details
  • Sbh Bioventure
    Co-Founder And Partner
    Sbh Bioventure
    Boston, Ma, Us
  • Endocure
    Board Member
    Endocure Jan 2023 - Present
    Kiryat Tivon, Haifa District, Israel
    Endocure is a Femtech company that is revolutionizing endometriosis diagnostics and treatment planning with a novel robotic AI-powered ultrasound. Their technology provides more accurate and timely diagnosis of endometriosis, as well as personalized treatment plans for each patient.
  • Amacathera
    Chairperson Of The Board
    Amacathera Oct 2024 - Present
    Toronto, Ontario, Canada
    AmacaThera is a pioneering biotechnology company revolutionizing drug delivery with its innovative platform, AmacaGel™. The company focuses on developing long-acting, cost-effective therapies for cancer and non-opioid analgesic applications, aiming to enhance patient outcomes and address critical unmet medical needs.
  • Keyron
    Executive Board Member And Co-Founder
    Keyron Aug 2021 - Present
    London, England, United Kingdom
    Keyron is aiming to reverse Diabesity. Keyron’s Forepass™ replicates Roux-en-Y Gastric Bypass (RYGB) gastric bypass surgery without the surgery. It’s the first device that can reverse diabetes.
  • Liliger Ltd
    Chief Technology Officer & Co-Founder
    Liliger Ltd Feb 2020 - Present
    Tel Aviv, Israel
    Liliger has developed a science-based line of cosmeceuticals, which renews the skin while simultaneously extends the effects of cosmetic treatments for maintaining a young & radiant appearance for an extended period.
  • Polyrizon Ltd.
    Chief Technology Officer
    Polyrizon Ltd. Mar 2020 - Present
    Ra'Ananna, Central, Israel
    Polyrizon is a pioneering biotech company dedicated to the development and commercialization of innovative intranasal products. With a focus on transforming drug delivery and improving patient outcomes, Polyrizon is shaping the future of biotech solutions.
  • Recma Bio
    Executive Board Member And Co-Founder
    Recma Bio Oct 2022 - Present
    Tel Aviv District, Israel
    Printing Organs - Printing LifeRECMA Bio is taking organ regeneration to the next level. We are combining biomaterial sciences, tissue engineering, 3D bioprinting, and robotics, to develop a robotic system for in-situ bioprinting, harnessing the body's natural abilities to regenerate and heal.
  • Sensei Ventures
    Managing Partner
    Sensei Ventures Jan 2016 - Present
    Greater Boston Area
    Mentor, Professional Director, Adviser and Serial Entrepreneur .
  • Madash, Llc
    Principal
    Madash, Llc Nov 1997 - Present
    Greater Boston Area
    MADASH, LLC is a consulting company founded and managed by Dr. Eyal S. Ron. MADASH supports Pharmaceutical, Biotechnology, Cosmeceutical and Nutraceutical companies to advance their product candidates rapidly and cost-efficiently from R&D to commercialization. MADASH’s support enhances the corporate value by providing expertise and out of the box creative thought process without building a costly infrastructure.
  • Sensei Biomaterials
    Founder And Principal
    Sensei Biomaterials Nov 2006 - Present
    Lexington, Massachusetts
    Novel Smart Biomaterials for consumer products, cosmetics and pharmaceutical applications
  • Sky Ventures Group
    Member
    Sky Ventures Group Jan 2017 - Present
    Boston, Massachusetts, United States
    A Boston-based investment group that provides funding to early-stage life science and healthcare companies. The Sky Ventures Group angel investors want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.
  • Addition Beauty
    Board Member
    Addition Beauty Dec 2022 - Nov 2024
    New York City Metropolitan Area
  • Addition Beauty
    Advisor / Mentor
    Addition Beauty Mar 2021 - Dec 2022
    New York City Metropolitan Area
    A FemTech that provides the first sustainable makeup line that supports fertility and pregnancy. The company's goal is to empower women with the knowledge to select safer cosmetics during a critical time of their lives without compromising beauty.
  • Embeba
    Advisor
    Embeba Aug 2020 - Nov 2024
    Boston, Massachusetts, United States
    Generation-Tested, Family Approved Remedies For Your Skin Sensitive Family® carefully curated from around the globe! Traditional remedies passed down for generations reformulated with the help of modern technology for the whole family.
  • Acousticabio
    Board Member
    Acousticabio Jan 2022 - May 2024
    Boston, Massachusetts, United States
    AcousticaBio's unique technology, patented by Harvard, transforms microscale fluid processing and is exceptionally effective for handling monoclonal antibodies. This technology surpasses the constraints of existing manufacturing processes. Targeting its initial market, AcousticaBio is focused on converting biologic products currently administered intravenously into formulations suitable for subcutaneous injection.
  • Pharmedica Ltd
    Member Of The Board Of Advisors
    Pharmedica Ltd May 2016 - Jun 2023
    Haifa, Israel
  • Pharmedica Ltd
    Member Board Of Directors
    Pharmedica Ltd Apr 2008 - Nov 2016
    Haifa, Israel
    PharMedica develops innovative polymer-based delivery platforms for controlled drug release, including patented orally dissolving films (ODFs) for needle-free, enhanced bioavailability. Their lead product, iCling™ for Dry Mouth, is commercially available. Learn more: pharmedica.co.il
  • Lvt - Laser Viral Technologies Ltd
    Executive Board Member
    Lvt - Laser Viral Technologies Ltd Jun 2021 - Dec 2022
    Yokneam, Northern, Israel
    A medical device startup, developing novel tools for selectively treat viral infections by laser-induced shockwave.
  • Acuitybio Corporation
    Member Board Of Directors
    Acuitybio Corporation Jan 2009 - Jul 2021
    Greater Boston Area
    AcuityBio Inc., was a developer of novel drug-delivery combination products to treat various types of early stage soft tissue cancers. AcuityBio was acquired (2021) by Cook Biotech, a leader in advanced biomaterials and regenerative medicines.
  • Flō Laboratories, Llc
    Co Founder
    Flō Laboratories, Llc Jun 2015 - Aug 2019
    Cambridge, Ma
    A market leader in highly efficacious, science-backed beauty products based on human physiology(TM) . The innovator of the Anti-Aging Skin Fitness Program.
  • Gelesis, Inc
    Cto (And Co-Founder)
    Gelesis, Inc Jan 2006 - Jul 2019
    Boston, Usa; And Calimera, Italy
    www.gelesis.comGelesis' first commercial product, Plenity(TM), is a first-of-its kind smart pill which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Plenity is indicated to aid in weight management in overweight and obese adults with a Body Mass Index (BMI) of 25 - 40 kg/m2, when used in conjunction with diet and exercise
  • Palmetto Pharmaceuticals, Inc.
    Cto (And Co-Founder)
    Palmetto Pharmaceuticals, Inc. Jan 1999 - Dec 2017
    Palmetto Pharmaceuticals is a drug development company specializing in combination therapies aimed at improving endothelial function, enhancing blood flow, and reducing triglycerides through the synergistic effects. Their nutraceutical product, L-Arginine Sustained Release (formerly Perfusia-SR), supports heart function, nitric oxide production, and optimal health, and is commercially available.
  • Combinent Biomedical Systems
    Chief Technology Officer And Founder
    Combinent Biomedical Systems Jan 1994 - Jan 2015
    Lexington, Massachusetts, United States
    A women’s healthcare company specializing in transvaginal drug delivery technology, successfully licensed to Dare Bioscience (darebioscience.com).
  • Polyrizon Ltd.
    Chief Technology Officer
    Polyrizon Ltd. Aug 2011 - Jan 2014
    Ra'Ananna, Central, Israel
    Polyrizon Ltd. is a Health Care seed-stage Company that develops novel biological-gels based on its novel Capture and Contain (C&C) platform technology. The C&C technology, with its unique specificity capabilities, can be readily adapted for a wide range of applications to protect human body from pathogens such as pollen, viruses, bacterium and more.
  • Oxford Pharmaceutical Services, Inc.
    Coo
    Oxford Pharmaceutical Services, Inc. Jun 2003 - Dec 2007
    Oxford Pharmaceutical Services specializing in the distributionof drugs to the health care community. Under leadership the company purchased the rights to Marplan form ROCHE and sold it profitably to Validus Pharmaceuticals
  • Neurohealing Pharmaceuticals, Inc
    Senior Director Of Formulation Development
    Neurohealing Pharmaceuticals, Inc Aug 2004 - Dec 2006
    http://www.neurohealing.comNeuroHealing is a clinical stage biopharmaceutical company developing innovative drug treatments for specialty indications based on neurologically active compounds.
  • Gelmed / Gel Sciences
    Cto / Coo And Founder
    Gelmed / Gel Sciences 1994 - 1997
    GelMed was an innovator of transmucosal drug delivery. Under leadership the company developed 2 proprietary platforms that were successfully tested in Phase 2 clinical studies. The company was sold successfully.
  • Gelmed / Gelsciences
    Founder, Coo, Cso
    Gelmed / Gelsciences 1994 - 1997
    Bedford, Massachusetts, United States
    GelMed was an innovator of SmartHydrogel(R) Transmucosal drug delivery. Under leadership the company developed 2 proprietary platforms that were successfully tested in Phase 2a clinical studies. The company was sold successfully.
  • Focal Inc.
    Director Of Pharmaceutical Development
    Focal Inc. 1992 - 1994
    Lexington, Massachusetts, United States
  • Genetics Institute
    Director
    Genetics Institute 1988 - 1991
    Massachusetts, United States
    Co-innovator of the Infuse® Spine Fusion product, a groundbreaking advancement in spinal surgery.
  • Enzytech / Opta
    Principal Investigator
    Enzytech / Opta 1987 - 1988
    Cambridge, Massachusetts, United States
  • Mit
    Post Doc
    Mit 1986 - 1987

Frequently Asked Questions about Eyal S. Ron

What company does Eyal S. Ron work for?

Eyal S. Ron works for Sbh Bioventure

What is Eyal S. Ron's role at the current company?

Eyal S. Ron's current role is Co-Founder and Partner.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.